Dystonia rating scales: critique and recommendations
- PMID: 23893443
- PMCID: PMC4207366
- DOI: 10.1002/mds.25579
Dystonia rating scales: critique and recommendations
Abstract
Many rating scales have been applied to the evaluation of dystonia, but only few have been assessed for clinimetric properties. The Movement Disorders Society commissioned this task force to critique existing dystonia rating scales and place them in the clinical and clinimetric context. A systematic literature review was conducted to identify rating scales that have either been validated or used in dystonia. Thirty-six potential scales were identified. Eight were excluded because they did not meet review criteria, leaving 28 scales that were critiqued and rated by the task force. Seven scales were found to meet criteria to be "recommended": the Blepharospasm Disability Index is recommended for rating blepharospasm; the Cervical Dystonia Impact Scale and the Toronto Western Spasmodic Torticollis Rating Scale for rating cervical dystonia; the Craniocervical Dystonia Questionnaire for blepharospasm and cervical dystonia; the Voice Handicap Index (VHI) and the Vocal Performance Questionnaire (VPQ) for laryngeal dystonia; and the Fahn-Marsden Dystonia Rating Scale for rating generalized dystonia. Two "recommended" scales (VHI and VPQ) are generic scales validated on few patients with laryngeal dystonia, whereas the others are disease-specific scales. Twelve scales met criteria for "suggested" and 7 scales met criteria for "listed." All the scales are individually reviewed in the online information. The task force recommends 5 specific dystonia scales and suggests to further validate 2 recommended generic voice-disorder scales in dystonia. Existing scales for oromandibular, arm, and task-specific dystonia should be refined and fully assessed. Scales should be developed for body regions for which no scales are available, such as lower limbs and trunk.
Keywords: blepharospasm; botulinum neurotoxins; dystonias; rating scales; torticollis.
© 2013 Movement Disorder Society.
Similar articles
-
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.Mov Disord. 2010 Jul 15;25(9):1131-42. doi: 10.1002/mds.23072. Mov Disord. 2010. PMID: 20310033
-
Botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004315. doi: 10.1002/14651858.CD004315.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2016 May 13;(5):CD004315. doi: 10.1002/14651858.CD004315.pub3. PMID: 15674941 Updated.
-
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.Mov Disord. 2010 Dec 15;25(16):2704-16. doi: 10.1002/mds.23190. Mov Disord. 2010. PMID: 20931631
-
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.Mov Disord. 2009 Apr 15;24(5):635-46. doi: 10.1002/mds.22260. Mov Disord. 2009. PMID: 19205066 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
Cited by
-
Deep Brain Stimulation Versus Peripheral Denervation for Cervical Dystonia: A Systematic Review and Meta-Analysis.World Neurosurg. 2019 Feb;122:e940-e946. doi: 10.1016/j.wneu.2018.10.178. Epub 2018 Nov 10. World Neurosurg. 2019. PMID: 30419402 Free PMC article.
-
Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?Mov Disord Clin Pract. 2023 Aug 3;10(9):1399-1403. doi: 10.1002/mdc3.13827. eCollection 2023 Sep. Mov Disord Clin Pract. 2023. PMID: 37772296 Free PMC article.
-
Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin.Neurol Sci. 2022 Dec;43(12):6929-6945. doi: 10.1007/s10072-022-06424-x. Epub 2022 Oct 3. Neurol Sci. 2022. PMID: 36190683
-
Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.Arq Neuropsiquiatr. 2024 Apr;82(4):1-7. doi: 10.1055/s-0044-1785691. Epub 2024 Apr 19. Arq Neuropsiquiatr. 2024. PMID: 38641339 Free PMC article.
-
Atrophy of cerebellar lobule VI and primary motor cortex in cervical dystonia - a region of interest-based study.J Neural Transm (Vienna). 2025 Feb;132(2):257-264. doi: 10.1007/s00702-024-02839-2. Epub 2024 Oct 7. J Neural Transm (Vienna). 2025. PMID: 39370479 Free PMC article.
References
-
- Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012;27:1789–96. - PubMed
-
- Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18:5–18. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous